157 related articles for article (PubMed ID: 35626034)
1. Integrin α2 and β1 Cross-Communication with mTOR/AKT and the CDK-Cyclin Axis in Hepatocellular Carcinoma Cells.
Juratli MA; Zhou H; Oppermann E; Bechstein WO; Pascher A; Chun FK; Juengel E; Rutz J; Blaheta RA
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626034
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like Growth Factor-1 Influences Prostate Cancer Cell Growth and Invasion through an Integrin α3, α5, αV, and β1 Dependent Mechanism.
Siech C; Rutz J; Maxeiner S; Grein T; Sonnenburg M; Tsaur I; Chun FK; Blaheta RA
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053528
[TBL] [Abstract][Full Text] [Related]
3. mTOR inhibition reduces growth and adhesion of hepatocellular carcinoma cells in vitro.
Engl T; Rutz J; Maxeiner S; Juengel E; Roos F; Khoder W; Bechstein WO; Nelson K; Tsaur I; Haferkamp A; Blaheta RA
Mol Med Rep; 2017 Nov; 16(5):7064-7071. PubMed ID: 28901501
[TBL] [Abstract][Full Text] [Related]
4. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
Ahmed N; Riley C; Rice G; Quinn M
Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
[TBL] [Abstract][Full Text] [Related]
5. Oscillatory flow-induced proliferation of osteoblast-like cells is mediated by alphavbeta3 and beta1 integrins through synergistic interactions of focal adhesion kinase and Shc with phosphatidylinositol 3-kinase and the Akt/mTOR/p70S6K pathway.
Lee DY; Li YS; Chang SF; Zhou J; Ho HM; Chiu JJ; Chien S
J Biol Chem; 2010 Jan; 285(1):30-42. PubMed ID: 19889638
[TBL] [Abstract][Full Text] [Related]
6. Role of beta1 integrins in adhesion and invasion of hepatocellular carcinoma cells.
Masumoto A; Arao S; Otsuki M
Hepatology; 1999 Jan; 29(1):68-74. PubMed ID: 9862852
[TBL] [Abstract][Full Text] [Related]
7. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.
Wong KF; Liu AM; Hong W; Xu Z; Luk JM
Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911
[TBL] [Abstract][Full Text] [Related]
8. β1 integrin-mediated multicellular resistance in hepatocellular carcinoma through activation of the FAK/Akt pathway.
Tian T; Li CL; Fu X; Wang SH; Lu J; Guo H; Yao Y; Nan KJ; Yang YJ
J Int Med Res; 2018 Apr; 46(4):1311-1325. PubMed ID: 29332411
[TBL] [Abstract][Full Text] [Related]
9. In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.
Casar B; Rimann I; Kato H; Shattil SJ; Quigley JP; Deryugina EI
Oncogene; 2014 Jan; 33(2):255-68. PubMed ID: 23208492
[TBL] [Abstract][Full Text] [Related]
10. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.
Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH
World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta1-mediated activations of c-Src and Rac1 modulate levels of cyclins and p27(Kip1) CDK inhibitor in hepatoma cells replated on fibronectin.
Kim HP; Kim TY; Lee MS; Jong HS; Kim TY; Lee JW; Bang YJ
Biochim Biophys Acta; 2005 Mar; 1743(1-2):151-61. PubMed ID: 15777850
[TBL] [Abstract][Full Text] [Related]
12. Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells.
You Y; Zheng Q; Dong Y; Xie X; Wang Y; Wu S; Zhang L; Wang Y; Xue T; Wang Z; Chen R; Wang Y; Cui J; Ren Z
Oncotarget; 2016 May; 7(22):32221-31. PubMed ID: 27050147
[TBL] [Abstract][Full Text] [Related]
13. Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis.
Wedel S; Hudak L; Seibel JM; Makarević J; Juengel E; Tsaur I; Waaga-Gasser A; Haferkamp A; Blaheta RA
BMC Cancer; 2011 Aug; 11():375. PubMed ID: 21867506
[TBL] [Abstract][Full Text] [Related]
14. Collagen I promotes hepatocellular carcinoma cell proliferation by regulating integrin β1/FAK signaling pathway in nonalcoholic fatty liver.
Zheng X; Liu W; Xiang J; Liu P; Ke M; Wang B; Wu R; Lv Y
Oncotarget; 2017 Nov; 8(56):95586-95595. PubMed ID: 29221151
[TBL] [Abstract][Full Text] [Related]
15. αv integrin processing interferes with the cross-talk between αvβ5/β6 and α2β1 integrins.
Defilles C; Montero MP; Lissitzky JC; Rome S; Siret C; Luis J; André F; Rigot V
Biol Cell; 2011 Nov; 103(11):519-29. PubMed ID: 21787362
[TBL] [Abstract][Full Text] [Related]
16. Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells.
Tsaur I; Makarević J; Juengel E; Gasser M; Waaga-Gasser AM; Kurosch M; Reiter M; Wedel S; Bartsch G; Haferkamp A; Wiesner C; Blaheta RA
Br J Cancer; 2012 Aug; 107(5):847-55. PubMed ID: 22782340
[TBL] [Abstract][Full Text] [Related]
17. Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network.
Yang J; Hou Y; Zhou M; Wen S; Zhou J; Xu L; Tang X; Du YE; Hu P; Liu M
Int J Biochem Cell Biol; 2016 Feb; 71():62-71. PubMed ID: 26693891
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma.
Sun F; Wang J; Sun Q; Li F; Gao H; Xu L; Zhang J; Sun X; Tian Y; Zhao Q; Shen H; Zhang K; Liu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):449. PubMed ID: 31684995
[TBL] [Abstract][Full Text] [Related]
19. The integrin, alpha6beta1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells.
Carloni V; Mazzocca A; Pantaleo P; Cordella C; Laffi G; Gentilini P
Hepatology; 2001 Jul; 34(1):42-9. PubMed ID: 11431732
[TBL] [Abstract][Full Text] [Related]
20. Role of integrin-linked kinase in regulating phosphorylation of Akt and fibroblast survival in type I collagen matrices through a beta1 integrin viability signaling pathway.
Nho RS; Xia H; Kahm J; Kleidon J; Diebold D; Henke CA
J Biol Chem; 2005 Jul; 280(28):26630-9. PubMed ID: 15905178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]